Sara
This user hasn't shared any biographical information
Homepage: http://www.collier-byrd.net/
Yahoo Messenger: SaraCollierByrd
Jabber/GTalk: s.collierbyrd
AIM: SaraCollierByrd
Posts by Sara
Oral drugs to treat multiple sclerosis could become available in 2011 after promising results in two trials.
Jan 21st
I am so glad I make a habit of reading BBC News daily as US news agencies frequently skim over important things in favor of the shocking or violent. Today they published a story about new oral multiple sclerosis treatments that are likely to be available in England in 2011. As someone whose liver does not particularly like Interferon and is afraid of the risk of death from Tysabri infusions this might be a godsend. Since interferons are not available as generics (they contain living organisms and are exempt from status that would let them ever become generic) this could open inexpensive and more successful treatment options to a host of people who have no option but to live with the effects of the disease untreated. The full article and link to it are pasted below, but here is the basic information you want:
- The oral drugs in question are Fingolimod and Cladribine
- The drugs are considerably more effective at reducing relapses than current available treatments
- The drugs may increase your chances of herpes and cancer
2009 Carolinas Consortium on Multiple Sclerosis
Nov 7th

National Multiple Sclerosis Society
The 2009 Carolinas Consortium on Multiple Sclerosis is next Saturday November 14th in Charlotte at the Westin Hotel. This event is run by the Mid-Atlantic Chapter of the National Multiple Sclerosis Society.
The consortium will run from 8:30 AM to 3:15 PM and features some great workshops, lectures on new and developing breakthroughs in multiple sclerosis treatment, and a catered lunch with a speech from a nationally recognized researcher in the field of multiple sclerosis.
The cost to attend is $12 per person (includes the cost of the catered lunch) and it sounds like the workshops and lectures will be extremely informative.


